V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210031271 | 210013032 | null | 24.1 | Curative (C) | 2018-06-25 | 2018-07-09 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 210038529 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 210031272 | 210013034 | 1.62 | 55.5 | Palliative (P) | 2016-12-29 | 2017-01-03 | Carboplatin AUC 2 - 5 | 01 | N | 210038531 | CARBOPLATIN |
| 210031273 | 210013036 | 1.86 | 102.6 | Curative (C) | 2017-12-30 | 2018-01-01 | ALL Int Guide A/B/C Maint Ph V | Y | N | 210038553 | ALL INTERIM GUIDELINES |
| 210031274 | 210022197 | 1.7 | null | Disease modification (D) | 2014-02-24 | 2014-06-09 | Chlorambucil | 02 | N | 210038557 | CHLORAMBUCIL |
| 210031275 | 210013042 | 1.59 | 28 | Curative (C) | 2013-01-13 | 2013-07-28 | ALL Int GdeC D Int PhIV recon Pasp | Y | N | 210038560 | ALL INTENSIFICATION |
| 210031276 | 210013042 | 1.75 | 26 | Curative (C) | 2016-08-17 | 2016-08-18 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | 210038560 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 210031277 | 210022199 | 1.71 | 64.5 | Curative (C) | 2017-05-06 | 2017-05-11 | ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp) | N | Y | 210038567 | UKALLR3 |
| 210031279 | 210013055 | 1.74 | null | Palliative (P) | 2015-11-15 | 2015-11-21 | Alemtuzumab(INTRAVENOUS) | N | N | 210038633 | ALEMTUZUMAB |
| 210031280 | 210013059 | 1.63 | 49.8 | Curative (C) | 2018-11-12 | 2019-01-20 | Chlorambucil | null | null | 210038641 | CHLORAMBUCIL |
| 210031281 | 210013061 | 1.61 | null | Disease modification (D) | 2017-08-23 | 2017-08-23 | AML Interim Guidelines FLAG-Ida | N | N | 210038656 | FLAG + IDARUBICIN |
| 210031282 | 210022210 | null | 75 | Curative (C) | 2015-11-10 | 2016-08-14 | Venetoclax | 02 | N | 210038667 | VENETOCLAX |
| 210031283 | 210013066 | 0 | 21.4 | Curative (C) | 2017-12-25 | 2017-12-25 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 210038669 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 210031284 | 210013078 | 1.61 | 77.7 | Disease modification (D) | 2014-01-29 | 2014-06-11 | Alemtuzumab(INTRAVENOUS) | null | N | 210038728 | ALEMTUZUMAB |
| 210031285 | 210022218 | null | 105 | Curative (C) | 2016-11-25 | 2016-12-01 | Alemtuzumab(INTRAVENOUS) | 99 | N | 210038733 | ALEMTUZUMAB |
| 210031286 | 210013082 | 1.68 | 101.6 | null | 2015-10-20 | 2015-10-25 | Alemtuzumab(INTRAVENOUS) | 02 | N | 210038741 | ALEMTUZUMAB |
| 210031287 | 210022224 | 0 | 76 | Palliative (P) | 2015-10-03 | 2015-10-06 | ETOPOSIDE | 99 | null | 210038791 | ETOPOSIDE |
| 210031288 | 210013095 | null | 21.5 | Curative (C) | 2016-06-17 | 2016-07-30 | MERCAPTOPURINE + METHOTREXATE | N | N | 210038811 | MERCAPTOPURINE + METHOTREXATE |
| 210031289 | 210013098 | null | 133 | Palliative (P) | 2017-06-30 | 2017-07-15 | FLAG + Idarubicin | N | N | 210038829 | FLAG + IDARUBICIN |
| 210031290 | 210013102 | 1.65 | 92 | Palliative (P) | 2012-04-18 | 2014-02-26 | Etoposide oral | 02 | N | 210038837 | ETOPOSIDE |
| 210031291 | 210013105 | null | 23.7 | Curative (C) | 2018-02-01 | 2018-03-15 | MERCAPTOPURINE + METHOTREXATE | 02 | N | 210038851 | MERCAPTOPURINE + METHOTREXATE |
| 210031292 | 210013110 | 1.68 | 65.1 | Palliative (P) | 2016-11-14 | 2017-01-09 | Chlorambucil | N | N | 210038868 | CHLORAMBUCIL |
| 210031293 | 210022230 | 1.41 | 83.4 | null | 2015-02-02 | 2015-02-06 | Chlorambucil | N | N | 210038871 | CHLORAMBUCIL |
| 210031294 | 210013112 | null | 55.6 | Disease modification (D) | null | 2013-12-01 | Mercaptopurine | N | N | 210038885 | MERCAPTOPURINE |
| 210031295 | 210013117 | null | 98 | Curative (C) | 2015-03-31 | 2015-09-21 | ALL Int GdeC D Int PhIV reind PAsp | N | N | 210038895 | ALL INTENSIFICATION |
| 210031296 | 210013120 | 1.58 | 80.4 | Disease modification (D) | 2017-11-17 | 2018-06-07 | Venetoclax | N | N | 210038900 | VENETOCLAX |
| 210031297 | 210013121 | 1.58 | 49 | Curative (C) | 2016-06-16 | 2016-06-16 | ALL Int Guide A/B/C Maint Ph V | N | N | 210038911 | ALL INTERIM GUIDELINES |
| 210031298 | 210013124 | null | 92 | Palliative (P) | 2019-01-26 | 2019-01-27 | Mercaptopurine | null | N | 210038930 | MERCAPTOPURINE |
| 210031299 | 210013127 | 1.82 | 26.8 | Not known (9) | 2013-02-20 | 2013-06-30 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 210038936 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 210031300 | 210013130 | null | 13.8 | Curative (C) | 2014-05-28 | 2014-06-04 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 210038937 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 210031301 | 210013131 | 1.64 | 52 | Curative (C) | 2014-03-15 | 2014-08-27 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | 210038940 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 210031302 | 210013134 | null | 67.4 | Curative (C) | 2015-12-11 | 2016-05-09 | MERCAPTOPURINE + METHOTREXATE | N | null | 210038943 | MERCAPTOPURINE + METHOTREXATE |
| 210031303 | 210013134 | 1.74 | 23 | Disease modification (D) | 2015-07-13 | 2015-07-15 | Alemtuzumab(INTRAVENOUS) | 2 | N | 210038943 | ALEMTUZUMAB |
| 210031304 | 210013137 | 1.56 | 53 | Curative (C) | 2016-07-13 | 2016-07-13 | Bevacizumab 15mg/kg | 02 | N | 210038999 | ERWINIA ASPARAGINASE |
| 210031305 | 210013139 | null | 94.2 | Palliative (P) | 2017-01-18 | 2017-04-08 | CVP R | null | null | 210039002 | BEVACIZUMAB |
| 210031306 | 210013140 | null | 80 | null | 2017-01-19 | 2017-01-19 | Methotrexate High Dose (3g/m2) | 02 | null | 210039006 | INOTUZUMAB OZOGAMICIN |
| 210031307 | 210022247 | null | 83.3 | Palliative (P) | 2017-05-21 | 2017-05-21 | Cyclophosphamide + Vincristine | N | null | 210039017 | IDELALISIB |
| 210031308 | 210035128 | 1.63 | 72 | Palliative (P) | 2018-10-24 | 2019-05-14 | CARBOPLATIN + VINCRISTINE | N | N | 210039036 | CARBOPLATIN + VINCRISTINE |
| 210031309 | 210013150 | null | 77 | Curative (C) | 2016-01-06 | 2016-01-08 | CHLORAMBUCIL + OFATUMUMAB | 02 | N | 210039055 | BENDAMUSTINE |
| 210031310 | 210013153 | 0 | null | Adjuvant (A) | 2013-07-11 | 2013-07-11 | Cyclophosphamide + Vincristine | 02 | N | 210039065 | RIALTO TRIAL |
| 210031311 | 210013157 | 1.91 | null | Adjuvant (A) | 2019-06-23 | 2019-08-20 | Procarbazine | N | N | 210039078 | PROCARBAZINE |
| 210031312 | 210013158 | 1.75 | 75.2 | Adjuvant (A) | 2013-07-26 | 2013-07-26 | Erwinase (Erwinia Asparaginase) | 2 | N | 210039080 | CVP R |
| 210031313 | 210013159 | 1.73 | null | Curative (C) | 2014-06-28 | 2014-09-30 | CYCLOPHOSPHAMIDE + FLUDARABINE | 02 | null | 210039086 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 210031314 | 210013163 | 1.56 | 18.2 | Adjuvant (A) | 2016-03-01 | 2016-09-23 | CHLORAMBUCIL + OFATUMUMAB | 02 | N | 210039105 | PENTOSTATIN |
| 210031315 | 210013164 | 1.78 | 17.4 | null | 2019-02-06 | 2019-05-09 | Vinblastine weekly | Y | N | 210039109 | VINBLASTINE |
| 210031316 | 210013166 | 1.68 | 80.9 | null | null | 2014-01-01 | Pentostatin | N | N | 210039110 | CHLORAMBUCIL + OFATUMUMAB |
| 210031317 | 210013169 | 1.79 | 95.4 | Neo-adjuvant (N) | 2016-01-15 | 2016-02-14 | PONATINIB | N | N | 210039126 | BENDAMUSTINE |
| 210031318 | 210013172 | 1.77 | null | Not known (9) | 2018-06-24 | 2018-06-24 | Dasatinib | null | N | 210039146 | DASATINIB |
| 210031319 | 210013175 | 1.63 | null | null | 2017-07-01 | 2017-07-01 | IDELALISIB | Y | null | 210039158 | CHOP |
| 210031320 | 210013178 | null | 18.5 | Adjuvant (A) | 2017-08-07 | 2018-12-19 | CHOP | null | Y | 210039177 | UKALL XII |
| 210031321 | 210013182 | 1.72 | null | Curative (C) | 2017-02-15 | 2017-05-12 | PONATINIB | N | N | 210039186 | CVP R |